
生物谷 — Investor Relations & Filings
Bio-Valley specializes in the research, development, and manufacturing of botanical-based therapeutic solutions, with a primary focus on cardiovascular and cerebrovascular health. The company is a leader in the industrialization of Erigeron breviscapus (Dengzhanhua), a botanical resource used for treating ischemic stroke and its sequelae. Its core product portfolio includes Dengzhan Shengmai Capsules and Dengzhan Xixin Injection, which are utilized in clinical settings for their neuroprotective and microcirculation-improving properties. Bio-Valley maintains a comprehensive value chain encompassing botanical cultivation, standardized extraction, and large-scale production. By leveraging advanced extraction technologies and rigorous quality control, the company provides evidence-based solutions for chronic disease management and geriatric care.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 回购股份方案公告 | 2022-08-23 | Chinese | |
| 第四届董事会第九次会议决议公告 | 2022-08-23 | Chinese | |
| 2022年半年度报告 | 2022-08-23 | Chinese | |
| 独立董事关于第四届董事会第九次会议相关事项的独立意见 | 2022-08-23 | Chinese | |
| 关于收到受理案件通知书的公告 | 2022-08-17 | Chinese | |
| 关于触发稳定股价措施启动条件的提示性公告 | 2022-08-10 | Chinese |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 39800177 | 回购股份方案公告 | 2022-08-23 | Chinese | ||
| 39800173 | 第四届董事会第九次会议决议公告 | 2022-08-23 | Chinese | ||
| 39800163 | 2022年半年度报告 | 2022-08-23 | Chinese | ||
| 39799930 | 独立董事关于第四届董事会第九次会议相关事项的独立意见 | 2022-08-23 | Chinese | ||
| 39799917 | 关于收到受理案件通知书的公告 | 2022-08-17 | Chinese | ||
| 39799908 | 关于触发稳定股价措施启动条件的提示性公告 | 2022-08-10 | Chinese | ||
| 39799901 | 关于保荐机构更名的公告 | 2022-07-31 | Chinese | ||
| 39799890 | 独立董事关于第四届董事会第八次会议相关事项的独立意见 | 2022-07-24 | Chinese | ||
| 39799884 | 关于调整公司第四届董事会专门委员会的公告 | 2022-07-24 | Chinese | ||
| 39799877 | 董事长、董事会秘书、监事会主席辞职公告 | 2022-07-24 | Chinese | ||
| 39799872 | 第四届监事会第四次会议决议公告 | 2022-07-24 | Chinese | ||
| 39799866 | 关于调整公司组织架构的公告 | 2022-07-24 | Chinese | ||
| 39799854 | 董事长、联席董事长、高级管理人员、监事会主席任命公告 | 2022-07-24 | Chinese | ||
| 39799840 | 第四董事会第八次会议决议公告 | 2022-07-24 | Chinese | ||
| 39799825 | 2022年第二次临时股东大会决议公告 | 2022-07-21 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
生物谷 via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58793/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58793 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58793 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58793 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58793}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for 生物谷 (id: 58793)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.